bf/NASDAQ:XBIT_icon.jpeg

NASDAQ:XBIT

XBiotech

  • Stock

USD

Last Close

2.39

06/11 22:06

Market Cap

190.97M

Beta: 1.21

Volume Today

55.25K

Avg: 29.25K

PE Ratio

−7.22

PFCF: −12.87

    Description

    XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stro...Show More

    Earnings

    Earnings per Share (Estimate*)

    -0.4-0.3-0.2-0.10.12017-08-082019-08-092021-08-092023-08-112024-08-09

    Revenue (Estimate*)

    5M10M15M20M2017-08-082019-08-092021-08-092023-08-112024-08-09

    *Estimate based on analyst consensus